Dr. Robert C. Knowlton, MD

Dr. Knowlton practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Knowlton's NPI, 1144257601, was assigned on June 28, 2006. Dr. Knowlton graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1989. Dr. Knowlton's Alabama license number on file is 22817.

Dr. Knowlton's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Knowlton's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Knowlton is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Knowlton to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Knowlton practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Knowlton's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Knowlton is board certified in clinical neurophysiology by the American Board of Clinical Neurophysiology. Dmand AI has Dr. Knowlton's licenses on file in 5 states: Alabama, California, Texas, Washington and Louisiana.

Dmand AI lists epilepsy, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain and seizures among the conditions Dr. Knowlton treats.

CMS data shows 302 Medicare services from Dr. Knowlton across 7 procedure codes in 2024, for 180 Medicare patients. Medicare paid $38,394 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 180 Medicare patients who saw Dr. Knowlton in 2024. The largest group is under 65, with 57 patients. 64% of them have high blood pressure, and 62% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Knowlton's median patient age at 39, with 59% women.

In 2024, Dr. Knowlton wrote 959 Medicare Part D claims for 112 patients. 68% of them were for generic drugs. CMS names the drug for 840 of them, across 25 drugs with 11 or more claims each, at $468,522 in total drug cost. In 2023, CMS named 943 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Knowlton for performance year 2024, reported as part of a group. Dr. Knowlton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Knowlton as offering telehealth.

Dmand AI links 107 papers to Dr. Knowlton, published from 2005 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Electroencephalography, Magnetic Resonance Imaging and Epilepsy, Temporal Lobe. Dr. Knowlton has published most often in Epilepsia. Dr. Knowlton's most frequent co-authors are Edward F. Chang, MD, Kenneth D. Laxer, MD and Vikram Ramnath Rao, MD, PhD.

Dmand AI links Dr. Knowlton to 3 clinical trials. Conditions studied include Epilepsy, Epilepsy, Temporal Lobe and Periventricular Nodular Heterotopia. University of California, San Francisco sponsors the most, 2.

CMS Open Payments shows 28 general payments to Dr. Knowlton from 6 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 36% of the total. Neuropace, Inc. paid the most, $5,438.

Dmand AI lists 8 awards for Dr. Knowlton, most recently CMS Stage 1 EHR in 2014.

Dr. Knowlton graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1989.

Dr. Knowlton is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.